These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 28965201)
1. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma. Topf MC; Wang ZX; Furlong K; Miller JL; Tuluc M; Pribitkin EA Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201 [TBL] [Abstract][Full Text] [Related]
2. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors. Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601 [TBL] [Abstract][Full Text] [Related]
3. TERT, HRAS, and EIF1AX Mutations in a Patient with Follicular Adenoma. Topf MC; Wang ZX; Tuluc M; Pribitkin EA Thyroid; 2018 Jun; 28(6):815-817. PubMed ID: 29669480 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules. Karunamurthy A; Panebianco F; J Hsiao S; Vorhauer J; Nikiforova MN; Chiosea S; Nikiforov YE Endocr Relat Cancer; 2016 Apr; 23(4):295-301. PubMed ID: 26911375 [TBL] [Abstract][Full Text] [Related]
5. A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma. Sponziello M; Silvestri G; Verrienti A; Perna A; Rosignolo F; Brunelli C; Pecce V; Rossi ED; Lombardi CP; Durante C; Filetti S; Fadda G Endocrine; 2018 Nov; 62(2):492-495. PubMed ID: 29700698 [No Abstract] [Full Text] [Related]
6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553 [TBL] [Abstract][Full Text] [Related]
7. Activating BRAF Mutations Detected in Mixed Hürthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland: Report of an Unusual Case and Review of the Literature. Sinno S; Choucair M; Nasrallah M; Wadi L; Jabbour MN; Nassif S Int J Surg Pathol; 2016 Sep; 24(6):519-24. PubMed ID: 27006301 [TBL] [Abstract][Full Text] [Related]
8. EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion. Castagna MG; Pilli T; Maino F; Marzocchi C; Cairano GD; Cantara S Arch Endocrinol Metab; 2020 Apr; 64(2):185-189. PubMed ID: 32236306 [TBL] [Abstract][Full Text] [Related]
10. Papillary Hürthle cell carcinoma (Warthin-like tumor) of the thyroid. Report of a case with fine needle aspiration findings. Vasei M; Kumar PV; Malekhoseini SA; Kadivar M Acta Cytol; 1998; 42(6):1437-40. PubMed ID: 9850656 [TBL] [Abstract][Full Text] [Related]
11. Hürthle cell lesions on thyroid fine needle aspiration cytology: Molecular and histologic correlation. Schatz-Siemers N; Brandler TC; Oweity T; Sun W; Hernandez A; Levine P Diagn Cytopathol; 2019 Oct; 47(10):977-985. PubMed ID: 31293091 [TBL] [Abstract][Full Text] [Related]
12. Characterization and Clinical Significance of EIF1AX Mutations and Co-Mutations in Cytologically Indeterminate Thyroid Nodules: A 5-Year Retrospective Analysis. Gargano SM; Badjatia N; Nikolaus Y; Peiper SC; Wang ZX Acta Med Acad; 2021 Apr; 50(1):4-12. PubMed ID: 34075760 [TBL] [Abstract][Full Text] [Related]
13. Molecular pathology of well-differentiated thyroid carcinomas. Sobrinho-Simões M; Preto A; Rocha AS; Castro P; Máximo V; Fonseca E; Soares P Virchows Arch; 2005 Nov; 447(5):787-93. PubMed ID: 16189702 [TBL] [Abstract][Full Text] [Related]
14. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration. Renshaw AA; Gould EW Cancer Cytopathol; 2016 Oct; 124(10):729-736. PubMed ID: 27322887 [TBL] [Abstract][Full Text] [Related]
15. Papillary Hürthle cell tumor of thyroid: report of a case with a cytomorphologic approach to diagnosis. Dziecioł J; Musiatowicz B; Zimnoch L; Kemona A; Sulkowski S Acta Cytol; 1996; 40(2):311-4. PubMed ID: 8629418 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737 [TBL] [Abstract][Full Text] [Related]
17. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of accordance between cytological and histopathological findings in selected thyroid tumors]. Gołkowski F; Jabrocka A; Huszno B; Trofimiuk M; Buziak-Bereza M; Kulig J; Cichoń S Przegl Lek; 2004; 61(1):10-2. PubMed ID: 15230098 [TBL] [Abstract][Full Text] [Related]
19. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm. Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826 [TBL] [Abstract][Full Text] [Related]
20. Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer. Alzahrani AS; Murugan AK; Qasem E; Alswailem MM; AlGhamdi B; Moria Y; Al-Hindi H Endocrine; 2019 Jan; 63(1):94-100. PubMed ID: 30269267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]